Addenbrookes NHS Trust

Cambridge CB2 0QQ

0 studies enrolling now · 3 studies all time

What they study most

Idiopathic Parkinson's Disease, Non-small Cell Lung Cancer (NSCLC), Rheumatoid Arthritis

Studies at this site

• A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) — Completed
• A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors — Completed
• Safinamide in Idiopathic Parkinson's Disease (IPD) With Motor Fluctuations, as add-on to Levodopa — Completed